loadpatents
name:-0.012760162353516
name:-0.014698028564453
name:-0.0052089691162109
von Geldern; Thomas W. Patent Filings

von Geldern; Thomas W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for von Geldern; Thomas W..The latest application filed is for "acylsulfonamide derivatives for treating senescence-associated diseases and disorders".

Company Profile
4.15.10
  • von Geldern; Thomas W. - Richmond IL
  • Von Geldern; Thomas W. - North Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
Grant 11,111,259 - Backes , et al. September 7, 2
2021-09-07
Acylsulfonamide Derivatives For Treating Senescence-associated Diseases And Disorders
App 20200291050 - Backes; Bradley ;   et al.
2020-09-17
Products Of Chiral Synthesis Of Cis-imidazoline Compounds And Their Use
App 20190270726 - von Geldern; Thomas W. ;   et al.
2019-09-05
Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use
Grant 10,329,279 - von Geldern , et al.
2019-06-25
Treatment of filarial diseases
Grant 10,238,677 - Von Geldern , et al.
2019-03-26
Chiral Synthesis Method For Producing Cis-imidazoline Compounds For Pharmaceutical Use
App 20180362510 - von Geldern; Thomas W. ;   et al.
2018-12-20
Tylosin A analogs and derivatives
Grant 10,072,040 - von Geldern , et al. September 11, 2
2018-09-11
Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use
Grant 9,988,368 - von Geldern , et al. June 5, 2
2018-06-05
Treatment Of Filarial Diseases
App 20170368088 - VON GELDERN; Thomas W. ;   et al.
2017-12-28
Tylosin A Analogs And Derivatives
App 20160200757 - von Geldern; Thomas W. ;   et al.
2016-07-14
Tylosin A Analogs And Derivatives
App 20150259374 - von Geldern; Thomas W. ;   et al.
2015-09-17
Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
Grant 8,748,412 - Liao , et al. June 10, 2
2014-06-10
Vitamin D receptor activators and methods of making
Grant 8,377,913 - Von Geldern , et al. February 19, 2
2013-02-19
Phenylalanine Derivatives And Their Use As Non-peptide Glp-1 Receptor Modulators
App 20120004198 - LIAO; Jiayu ;   et al.
2012-01-05
Vitamin D Receptor Activators And Methods Of Making
App 20090131379 - Von Geldern; Thomas W. ;   et al.
2009-05-21
Endothelin antagonists
Grant 7,365,093 - Winn , et al. April 29, 2
2008-04-29
Endothelin antagonists
Grant 7,208,517 - Winn , et al. April 24, 2
2007-04-24
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
App 20060264433 - Backes; Bradley J. ;   et al.
2006-11-23
Endothelin antagonists
App 20060229280 - Winn; Martin ;   et al.
2006-10-12
Endothelin antagonists
Grant 6,946,481 - Winn , et al. September 20, 2
2005-09-20
Endothelin antagonists
Grant 5,767,144 - Winn , et al. June 16, 1
1998-06-16
Angiotensin II receptor antagonists
Grant 5,326,776 - Winn , et al. July 5, 1
1994-07-05
Angiotensin II receptor antagonists
Grant 5,250,548 - Winn , et al. October 5, 1
1993-10-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed